Baseline evaluation of routine HIV testing among tuberculosis patients in Botswana

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 3 SUPPL. 1, 2008, Pages

  Gammino, Victoria M ^a   Mboya, J J ^b   Samandari, T ^a,b   Sheth, A ^b   Almquist, J ^b   Nkubito, G ^b   Jimbo, W ^c   Obita, G ^d   Roels, T H ^b,c   Wells, C D ^a   Kilmarx, P H ^b,c   Nelson, L J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Department of HIV AIDS Prevention and Care   (Botswana)

^c BOTUSA Project   (Botswana)

^d Ministry of Local Government   (Botswana)

Author keywords

Botswana; Routine HIV testing; TB HIV surveillance; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT;

ANALYTIC METHOD; ARTICLE; BOTSWANA; CONTROLLED STUDY; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; SCREENING TEST; TUBERCULOSIS;

AIDS SERODIAGNOSIS; ANTI-HIV AGENTS; BOTSWANA; CROSS-SECTIONAL STUDIES; HEALTH POLICY; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; MASS SCREENING; REGISTRIES; TUBERCULOSIS; VOLUNTARY PROGRAMS;

EID: 40549084326     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Corbett E L, Watt C J, Walker N, et al. The growing burden of tuberculosis. Arch Intern Med 2003; 163: 1009-1021.
2. National AIDS Coordinating Agency/Central Statistics Office. Botswana AIDS impact survey II 2004, statistical report. Gaborone, Botswana: NACA/CSO, 2005.
3. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2006. WHO/HTM/TB/2006.362. Geneva, Switzerland: WHO, 2006.
4. Nelson L J, Talbot E A, Mwasekaga M J, et al. Anti-tuberculosis drug resistance and anonymous HIV surveillance among tuberculosis patients - Botswana, 2002. Lancet 2005; 366: 488-490.
5. Talbot E A, Hay Burgess D C, Hone N M, et al. Tuberculosis serodiagnosis in a predominantly HIV-infected population of hospitalized patients with cough, Botswana 2002. Clin Infect Dis 2004; 39: e1-7.
6. Darkoh E. The MASA antiretroviral therapy program in Botswana: update, challenges and lessons learned. Gaborone, Botswana: Ministry of Health, 2004.
7. Khan A, Tryon C, Stinson K W, et al. TB-HIV train-the-trainer surveillance training in Botswana. Paris, France: 37th Union World Conference on Lung Health, 2006. Int J Tuberc Lung Dis 2006; 9 (Suppl); S17.
8. Viera A J, Garrett J M. Understanding interobserver agreement: the kappa statistic. Fam Med 2005; 37: 360-363.
9. Lockman S, Hone N M, Kenyon T A, et al. Etiology of pulmonary infections in predominantly HIV-infected adults with suspected tuberculosis, Botswana. Int J Tuberc Lung Dis 2003; 7: 714-723.
10. Botswana Ministry of Health. Botswana National TB Program annual report 2004. Gaborone, Botswana: Ministry of Health, 2004.
11. Anabwani G, Jimbo W, eds. Botswana guidelines on antiretroviral treatment. Gaborone Botswana: Ministry of Health, 2005.